I2Cure Pte. Limited logo — No more temporary superficial care.
World's 1st Molecular Io...

I2Cure Pte. Limited

No more temporary superficial care. World's 1st Molecular Iodine-based Personal care brand!

Founded 2020 Singapore Singapore 43 employees Biotechnology, Manufacturing +2

General Information

Company Name I2Cure Pte. Limited
Founded Year 2020
Location Singapore Singapore +3
Employees 43
Industries Biotechnology, Manufacturing, Pharmaceutical +1
Social

Get notified when I2Cure Pte. Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About I2Cure Pte. Limited

I2Cure Pte. Limited

Slogan: No more temporary superficial care. World's 1st Molecular Iodine-based Personal care brand!

Description: I2Cure Pte Limited is a global biotech company founded by an IIT-Kanpur alumnus and backed by research Institutions. The first to bring the world a broad range of Pharmaceutical & Cosmeceutical products with the breakthrough in advanced Molecular Iodine (I₂) Science. All the products manufactured are based on patented Advanced Molecular Iodine (I₂) technology, in India, for the world.

Founded: 2020

Industries: Biotechnology, Manufacturing, Pharmaceutical

Headquarter: Singapore

Last Investment: N/A

Last Investment Investors: N/A

I2Cure Pte. Limited is a pioneering biotech company disrupting the personal care industry with its innovative Molecular Iodine-based products. Founded in 2020, the company is headquartered in Singapore and led by an IIT-Kanpur alumnus, backed by research institutions. Their patented Advanced Molecular Iodine (I₂) technology has the potential to revolutionize the pharmaceutical and cosmeceutical sectors globally. With a strong focus on biotechnology, manufacturing, and pharmaceuticals, I2Cure is poised to make a significant impact in these industries. Despite the absence of disclosed last investment details, the company's unique proposition and technological advancements make it a compelling prospect for potential investors.

Taxonomy: biotech, personal care, cosmeceutical, pharmaceutical, Molecular Iodine, dermatology, gynaecology, skincare, covid defense, dental care, hair care, hygiene, intimate care, nasal care

No funding data available for I2Cure Pte. Limited yet.

Get notified when I2Cure Pte. Limited raises funding

I2Cure Pte. Limited Alternatives & Competitors

I2Cure Pte. Limited vs

World leader in molecular iodine research and development

Unknown
16 employees
Biotechnology, Health Care
I2Cure Pte. Limited vs

Comprehensive Care for Endocrine and Diabetes Needs

11 employees
Health Care
I2Cure Pte. Limited vs
LEX Diagnostics
LEX Diagnostics United Kingdom

Molecular diagnostics for primary care.

41 employees
Biotechnology, Care Economy

FAQ About I2Cure Pte. Limited

No more temporary superficial care. World's 1st Molecular Iodine-based Personal care brand!
I2Cure Pte. Limited was founded in 2020.
I2Cure Pte. Limited is headquartered in Singapore.
I2Cure Pte. Limited operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical, Wellness Beauty.
I2Cure Pte. Limited has approximately 43 employees.
Top alternatives and competitors to I2Cure Pte. Limited include IoTech International, Inc., Central Florida Endocrine, LEX Diagnostics, Medcura, Inc., Genesystem. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
I2Cure Pte. Limited and IoTech International, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors I2Cure Pte. Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes